There was no single adverse reaction leading to discontinuation that happened in a price of >2% in CAPLYTA-dealt with clients. Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic actions, might create in patients handled with antipsychotic prescriptio